BRAZIL currently marketed by the company are Insunorm , Calman , Phillips Milk of Magnesia , Digoxin , Agrastat , Imuran , Aldosterin , Aldomet , Indocid , Kwell and Zyloric . Aspen Pharma Brazil also has a line of hospital products including Eutropin , Cellexina , Aldosterin , Formet and others .
Focusing on business development , the company has an ongoing expansion plan . Aspen Pharma Brazil ’ s CEO , Alexander France , states : “ For 2015 , the company intends to expand the production capacity and the infrastructure in Sierra . In addition , we have plans to invest in the sector and launch a new phytotherapeutic product at the end of the year .”
GROWTH AND QUALITY The grand growth strategy is to acquire major brands . In August 2012 , Aspen Pharma Brazil commercialized Phillips Milk of Magnesia , Kwell and Nedax , formerly controlled by GlaxoSmithKline ( GSK ).
To control operation quality the company invests in a process of improvement . “ In a recent continuous improvement project , we achieved a 40 percent reduction of time spent in one of the stages of the manufacturing process . This resulted in the optimization of productive capacity ,” explains the CEO .
Above all , the plant meets all programs required by legislation , including good manufacturing practices , medicine and occupational health , accident prevention and health care waste
Aspen Pharma meeting room , Rio de Janeiro
Aspen Pharma reception room , Rio de Janeiro
www . aspenpharma . com . br 149